Advertisement
Advertisement
October 30, 2024
Vesalio Initiates Real-World Study of pVasc Thrombectomy System
October 30, 2024—Vesalio recently announced the initiation of a prospective, single-arm, multicenter study supporting the company’s pVasc thrombectomy system for nonsurgically removing peripheral occlusions.
According to the company, this multidisciplinary clinical research initiative aims to collect real-world insights on the pVasc system in treating patients with peripheral arterial disease (PAD) occlusions that may lead to acute limb ischemia (ALI). The pVasc study will seek evidence to support the optimization of revascularization techniques and outcomes for patients with PAD-related conditions such as ALI.
On September 4, Vesalio announced the United States launch of the pVasc system in the United States. The device is indicated for arteries from 2 to 6 mm in diameter, which are typically located below the knee, in the femoropopliteal, the mesenteric, the upper extremities, and a few other locations, noted the company.
Advertisement
Advertisement
